Does Chronic Kidney Disease Facilitate Malignant Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction of Hypertensive Origin?
In hypertensive patients with heart failure (HF) a serum biomarker combination of high carboxy-terminal propeptide of procollagen type-I (PICP) and low carboxy-terminal telopeptide of collagen type-I to matrix metalloproteinase-1 (CITP:MMP-1) ratio identifies a histomolecular phenotype of malignant...
Main Authors: | Rocio Eiros, Gregorio Romero-González, Juan Jose Gavira, Oscar Beloqui, Inmaculada Colina, Manuel Fortún Landecho, Begoña López, Arantxa González, Javier Díez, Susana Ravassa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/2/404 |
Similar Items
-
Extracellular Vesicles Mediate of Cardiac Fibrosis in Heart Failure With Preserved Ejection Fraction
by: Maria Luisa Gomes Cerqueira
Published: (2021) -
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
by: Mark Sweeney, et al.
Published: (2020-10-01) -
Left ventricular fibrosis and hypertrophy are associated with mortality in heart failure with preserved ejection fraction
by: Pankaj Garg, et al.
Published: (2021-01-01) -
Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension
by: Ravi B. Patel, et al.
Published: (2020-02-01) -
Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction.
by: Shunsuke Tamaki, et al.
Published: (2013-01-01)